Sanofi

OTC: SNYNF · Real-Time Price · USD
101.18
0.13 (0.13%)
At close: Aug 18, 2025, 2:31 PM

Sanofi Income Statement

Financials in EUR. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
43.13B 53.6B 54.12B 69.37B 67.91B 57.38B 57.13B 45.7B 46.14B 46.2B 45.39B 44.35B 42.04B 40.34B 39.17B 38.5B 37.55B 36.94B
Cost of Revenue
12.24B 17.17B 17.72B 24.51B 24.27B 19.61B 19.25B 13.92B 13.91B 13.89B 13.7B 13.44B 12.84B 12.45B 12.25B 12.22B 12.15B 11.98B
Gross Profit
30.89B 36.43B 36.39B 44.85B 43.64B 37.77B 37.88B 31.78B 32.23B 32.3B 31.69B 30.91B 29.2B 27.89B 26.92B 26.28B 25.39B 24.96B
Operating Income
8.58B 11.7B 10.87B 14.46B 14.03B 11.29B 12.31B 9.48B 8.99B 8.57B 8.5B 8.03B 8.35B 8.47B 8.13B 8.16B 7.74B 14.24B
Interest Income
332M 348M 413M 661M 671M 704M 714M 584M 493M 392M 241M 96M 46M 38M 42M 39M 113M 105M
Pretax Income
8.28B 9.59B 8.74B 10.58B 10.04B 9.08B 10.19B 9.2B 8.83B 8.4B 8.27B 7.74B 8.02B 8.15B 7.8B 7.82B 7.32B 13.81B
Net Income
9.13B 7.43B 6.69B 8.16B 7.87B 7.06B 7.92B 7.42B 6.97B 6.71B 6.72B 6.39B 6.63B 6.67B 6.22B 6.17B 5.81B 12.2B
Selling & General & Admin
8.78B 11.4B 11.79B 16.06B 15.95B 13.27B 13.27B 10.66B 10.72B 10.72B 10.49B 10.36B 9.98B 9.74B 9.55B 9.4B 9.31B 9.24B
Research & Development
7.69B 9.2B 9.11B 10.53B 10.34B 8.55B 8.39B 6.68B 6.75B 6.78B 6.71B 6.47B 6.17B 5.91B 5.69B 5.62B 5.5B 5.46B
Other Expenses
6.46B 4.73B 3.25B 1.82B -79M -79M -88M -321M -316M -440M -370M -138M -147M -23M -5M -4M n/a n/a
Operating Expenses
22.93B 25.34B 25.36B 29.61B 28.58B 25.15B 24.66B 20.97B 20.23B 20.19B 19.81B 19.58B 19.3B 18.4B 17.77B 17.29B 17.08B 16.97B
Interest Expense
661M 709M 749M 966M 1.02B 1.09B 1B 868M 653M 552M 472M 385M 369M 380M 391M 399M 312M 300M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.6B 2.6B 4.87B
Cost & Expenses
35.16B 42.51B 43.08B 54.13B 52.85B 44.76B 43.91B 34.89B 34.14B 34.09B 33.51B 33.01B 32.14B 30.85B 30.02B 29.5B 29.24B 28.95B
Income Tax Expense
1.64B 1.87B 1.55B 2.24B 2.06B 1.87B 2.17B 1.7B 1.74B 1.63B 1.5B 1.36B 1.37B 1.49B 1.56B 1.62B 1.5B 1.78B
Shares Outstanding (Basic)
1.23B 1.23B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B 1.25B
Shares Outstanding (Diluted)
1.23B 1.23B 1.25B 1.25B 1.25B 1.25B 1.26B 1.25B 1.25B 1.25B 1.26B 1.25B 1.25B 1.25B 1.25B 1.25B 1.26B 1.25B
EPS (Basic)
7.36 5.97 5.36 6.53 6.29 7.23 7.92 7.52 7.17 5.37 5.38 5.11 5.29 6.57 6.21 6.17 5.88 11.07
EPS (Diluted)
7.36 5.96 5.35 6.51 6.27 7.21 7.90 7.50 7.15 5.36 5.37 5.11 5.29 6.56 6.20 6.16 5.87 11.04
EBITDA
9.47B 9.61B 9B 10.08B 9.75B 10.2B 11.15B 12.22B 11.76B 11.92B 11.67B 10.89B 11.02B 10.67B 10.27B 10.41B 10.26B 16.48B
EBIT
8B 8.02B 7.25B 6.75B 6.33B 6.73B 7.76B 12.16B 11.59B 11.11B 10.89B 8.15B 8.41B 8.55B 8.21B 8.19B 7.77B 14.25B
Depreciation & Amortization
1.47B 2.55B 2.71B 5.49B 5.58B 5.97B 5.9B 4.52B 4.42B 4.39B 4.35B 4.37B 4.29B 4.2B 4.14B 4.18B 4.62B 4.91B